Literature DB >> 1356887

Three year follow up of patients with gastrooesophageal reflux disease.

N E Schindlbeck1, A G Klauser, G Berghammer, W Londong, S A Müller-Lissner.   

Abstract

Data on the natural course of gastrooesophageal reflux disease are sparse. One hundred and sixty six patients with typical reflux symptoms (heartburn and/or acid regurgitation) and pathologic pH monitoring (reflux time > 8.2% upright and/or > 3.0% supine) were studied. The patients were followed up by questionnaire and interview for a mean of 41 (seven to 86) months after diagnosis of reflux disease. Ten patients had died of diseases not reflux related. In 117 (75%) of the remaining 156 patients data on the course of gastrooesophageal reflux disease could be obtained. In 12 patients anti reflux surgery had been performed. Forty one (39%) of the remaining 105 patients have stopped taking medical therapy, in 13 of these patients symptoms had completely disappeared. Sixty four patients continued on medication (40 on demand, 24 regularly). When asked how their symptoms would be if they completely stopped medication, 71 patients considered their symptoms to be equal or worse and 21 patients to be improved as compared with the initial investigation. Patients with persisting symptoms at follow up had significantly more supine reflux (p < 0.05) at the initial pH monitoring as compared with patients with improved symptoms. The presence and grade of oesophageal erosions at initial endoscopy, duration of symptoms, age, sex, and smoking habits had no influence on the course of gastrooesophageal reflux disease. In conclusion, reflux symptoms disappear only in a minority of patients with proven gastrooesophageal reflux disease. More than half of all patients continue medication, either on demand or regularly. Severe supine reflux is an unfavourable prognostic factor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356887      PMCID: PMC1379433          DOI: 10.1136/gut.33.8.1016

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode?

Authors:  A G Klauser; N E Schindlbeck; S A Müller-Lissner
Journal:  Am J Gastroenterol       Date:  1990-11       Impact factor: 10.864

2.  Esophageal hiatal hernia: a 10-year study of medically treated cases.

Authors:  J C REX; H A ANDERSEN; L G BARTHOLOMEW; J C CAIN
Journal:  JAMA       Date:  1961-10-21       Impact factor: 56.272

3.  Medical and surgical management of reflux esophagitis. A 38-month report of a prospective clinical trial.

Authors:  J Behar; D G Sheahan; P Biancani; H M Spiro; E H Storer
Journal:  N Engl J Med       Date:  1975-08-07       Impact factor: 91.245

4.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

Authors:  D J Hetzel; J Dent; W D Reed; F M Narielvala; M Mackinnon; J H McCarthy; B Mitchell; B R Beveridge; B H Laurence; G G Gibson
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

5.  Epidemiology of oesophageal reflux disease.

Authors:  R C Heading
Journal:  Scand J Gastroenterol Suppl       Date:  1989

6.  Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine.

Authors:  B Kaul; H Petersen; H Erichsen; H E Myrvold; K Grette; T Halvorsen; U Fjøsne
Journal:  Scand J Gastroenterol       Date:  1986-03       Impact factor: 2.423

7.  Which pH threshold is best in esophageal pH monitoring?

Authors:  N E Schindlbeck; H Ippisch; A G Klauser; S A Müller-Lissner
Journal:  Am J Gastroenterol       Date:  1991-09       Impact factor: 10.864

8.  Symptomatic gastroesophageal reflux: incidence and precipitating factors.

Authors:  O T Nebel; M F Fornes; D O Castell
Journal:  Am J Dig Dis       Date:  1976-11

9.  Technique, indications, and clinical use of 24 hour esophageal pH monitoring.

Authors:  T R DeMeester; C I Wang; J A Wernly; C A Pellegrini; A G Little; P Klementschitsch; G Bermudez; L F Johnson; D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1980-05       Impact factor: 5.209

10.  Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease.

Authors:  N E Schindlbeck; C Heinrich; A König; A Dendorfer; F Pace; S A Müller-Lissner
Journal:  Gastroenterology       Date:  1987-07       Impact factor: 22.682

View more
  35 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  Natural history of dyspepsia.

Authors:  Lars Agréus
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 3.  Assessment of reflux symptom severity: methodological options and their attributes.

Authors:  P Bytzer
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

4.  A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms.

Authors:  Johanna I Westbrook; Anne E Duggan; John M Duggan; Mary T Westbrook
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 5.  Heterogeneity of endoscopy negative heartburn: epidemiology and natural history.

Authors:  Fabio Pace; Valentina Casini; Stefano Pallotta
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

6.  Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.

Authors:  Roger Jones; Silke Horbach; Peter Sander; Tina Rydén-Bergsten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication.

Authors:  Awais Ashfaq; Hyun K Daniel Rhee; Kristi L Harold
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Quality-of-life assessments in evaluation of laparoscopic Rosetti fundoplication.

Authors:  H Glise; B Hallerbäck; B Johansson
Journal:  Surg Endosc       Date:  1995-02       Impact factor: 4.584

9.  Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure.

Authors:  Fabio Pace; Stefano Pallotta; Gianpiero Manes; Annalisa de Leone; Patrizia Zentilin; Luigi Russo; Vincenzo Savarino; Matteo Neri; Enzo Grossi; Rosario Cuomo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

10.  Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients.

Authors:  E Kuster; E Ros; V Toledo-Pimentel; A Pujol; J M Bordas; L Grande; C Pera
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.